T., B.; R., R. K.; R., A. C.; P., A.; S., D.; R., J. Effect of casirivimab-imdevimab on mild COVID-19 patients with diabetes in reducing oxygen supplementation at 28 days: an observational study. International Journal of Research in Medical Sciences, [S. l.], v. 10, n. 9, p. 1983–1987, 2022. DOI: 10.18203/2320-6012.ijrms20222277. Disponível em: https://www.msjonline.org/index.php/ijrms/article/view/10966. Acesso em: 27 sep. 2025.